DAM
NVO

Directional Asset Management’s Novo Nordisk NVO Stock Holding History

Directional Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,185
Closed -$867K – 101
2026
Q1 		$742K Buy
20,185
+10,740
+114% +$509K 0.68% 38
2025
Q4 		$481K Buy
+9,445
New +$483K 0.42% 60

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Directional Asset Management's NVO Position: Q2 2026 in Review

Directional Asset Management sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 20,185 shares — an estimated $867K sold.

Directional Asset Management first reported a position in NVO in Q4 2025 and held it in 2 quarters. The position peaked at $742K in Q1 2026. 1,346 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Directional Asset Management reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Directional Asset Management sold 20,185 Novo Nordisk shares in Q2 2026, an estimated $867K.
  • Directional Asset Management first reported a position in Novo Nordisk in Q4 2025 and held it in 2 quarters.
  • Directional Asset Management's Novo Nordisk position peaked at $742K in Q1 2026.
  • 1,346 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Directional Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.